Treatment of melanoma cells with increasing doses of both inhibitors for 12 h led to a strong upregulation of SOX2 at both mRNA and protein levels (Figs. 1, A–C and S1), in line with previous reports (14, 15, 18). The gene discussed is SOX2; the disease is melanoma.